OrthoPediatrics Corp. Forecast, price target & analysts
OrthoPediatrics Corp. Target price 2025 - Analyst rating & recommendation
OrthoPediatrics Corp. Classifications & Recommendation:
OrthoPediatrics Corp. Price Target
| Target Price | $40.17 |
| Price | $22.89 |
| Potential |
75.48%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target OrthoPediatrics Corp. 2026 .
The average OrthoPediatrics Corp. target price is $40.17.
This is
75.48%
register free of charge
$50.00
118.44%
register free of charge
$25.00
9.22%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend OrthoPediatrics Corp. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the OrthoPediatrics Corp. stock has an average upside potential 2026 of
75.48%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 148.73 | 203.06 |
| 21.62% | 36.53% | |
| EBITDA Margin | -5.63% | 4.20% |
| 17.08% | 174.54% | |
| Net Margin | -15.14% | -14.75% |
| 1,374.45% | 2.57% |
6 Analysts have issued a sales forecast OrthoPediatrics Corp. 2024 . The average OrthoPediatrics Corp. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an OrthoPediatrics Corp. EBITDA forecast 2024. The average OrthoPediatrics Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 OrthoPediatrics Corp. Analysts have issued a net profit forecast 2024. The average OrthoPediatrics Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.93 | -1.24 |
| 1,650.00% | 33.33% | |
| P/E | negative | |
| EV/Sales | 2.72 |
4 Analysts have issued a OrthoPediatrics Corp. forecast for earnings per share. The average OrthoPediatrics Corp. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the OrthoPediatrics Corp. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
OrthoPediatrics Corp....
Current OrthoPediatrics Corp. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham | Locked ➜ Locked | Locked | Jan 14 2025 |
| Truist Securities | Locked ➜ Locked | Locked | Dec 18 2024 |
| Needham | Locked ➜ Locked | Locked | Nov 08 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Oct 14 2024 |
| JMP Securities | Locked ➜ Locked | Locked | Sep 13 2024 |
| Needham | Locked ➜ Locked | Locked | Sep 13 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Sep 13 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham: Locked ➜ Locked
|
Jan 14 2025 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Dec 18 2024 |
|
Locked
Needham: Locked ➜ Locked
|
Nov 08 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Oct 14 2024 |
|
Locked
JMP Securities: Locked ➜ Locked
|
Sep 13 2024 |
|
Locked
Needham: Locked ➜ Locked
|
Sep 13 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Sep 13 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
